Nisa Investment Advisors
AKBA icon

Nisa Investment Advisors’s Akebia Therapeutics AKBA Stock Holding History

Nisa Investment Advisors’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.52K Buy
3,088
+55
+2% +$65 ﹤0.01% 2671
2026
Q1 		$4.22K Buy
3,033
+78
+3% +$107 ﹤0.01% 2488
2025
Q4 		$4.76K Sell
2,955
-66
-2% -$138 ﹤0.01% 2458
2025
Q3 		$8.25K Hold
3,021
– – ﹤0.01% 2332
2025
Q2 		$11K Buy
3,021
+2,355
+354% +$6.47K ﹤0.01% 2220
2025
Q1 		$1.28K Buy
666
+66
+11% +$135 ﹤0.01% 2576
2024
Q4 		$1.14K Hold
600
– – ﹤0.01% 2650
2024
Q3 		$792 Buy
+600
New +$801 ﹤0.01% 2626
2022
Q2 		– Sell
-1,608
Closed -$1K – 2368
2022
Q1 		$1K Sell
1,608
-354,600
-100% -$759K ﹤0.01% 2350
2021
Q4 		$709K Sell
356,208
-6,000
-2% -$16.4K 0.01% 927
2021
Q3 		$1.04M Hold
362,208
– – 0.01% 894
2021
Q2 		$1.37M Buy
362,208
+20,000
+6% +$67.3K 0.01% 826
2021
Q1 		$1.16M Hold
342,208
– – 0.01% 901
2020
Q4 		$958K Buy
342,208
+335,950
+5,368% +$981K 0.01% 943
2020
Q3 		$16K Buy
6,258
+4,650
+289% +$40.8K ﹤0.01% 2060
2020
Q2 		$22K Buy
1,608
+380
+31% +$3.93K ﹤0.01% 1756
2020
Q1 		$9K Hold
1,228
– – ﹤0.01% 1861
2019
Q4 		$8K Hold
1,228
– – ﹤0.01% 1862
2019
Q3 		$5K Buy
1,228
+850
+225% +$3.64K ﹤0.01% 1892
2019
Q2 		$2K Hold
378
– – ﹤0.01% 1970
2019
Q1 		$3K Hold
378
– – ﹤0.01% 1964
2018
Q4 		$2K Buy
+378
New +$2.96K ﹤0.01% 1905

Other funds holding AKBA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nisa Investment Advisors's AKBA Position: Q2 2026 in Review

Nisa Investment Advisors increased its Akebia Therapeutics (AKBA) stake by 1.8% in Q2 2026, buying an estimated $65 and bringing the position to 3,088 shares worth $3.52K. The position accounts for ﹤0.01% of the portfolio, ranked #2671.

Nisa Investment Advisors first reported a position in AKBA in Q4 2018 and has held it in 22 quarters since. The position peaked at $1.37M in Q2 2021. 170 funds tracked by Wall St. Rank hold AKBA as of Q2 2026.

  • Nisa Investment Advisors held 3,088 shares of Akebia Therapeutics worth $3.52K as of Q2 2026.
  • Nisa Investment Advisors bought 55 Akebia Therapeutics shares in Q2 2026, an estimated $65.
  • Akebia Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2671 holding.
  • Nisa Investment Advisors first reported a position in Akebia Therapeutics in Q4 2018 and has held it in 22 quarters since.
  • Nisa Investment Advisors's Akebia Therapeutics position peaked at $1.37M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.